ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 172 filers reported holding ACCELERON PHARMA INC in Q3 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $162,000 | -14.3% | 4,101 | -10.9% | 0.01% | -14.3% |
| Q2 2019 | $189,000 | -89.2% | 4,603 | -87.8% | 0.01% | -90.8% |
| Q1 2019 | $1,756,000 | +6.9% | 37,700 | 0.0% | 0.08% | -23.2% |
| Q4 2018 | $1,642,000 | -55.3% | 37,700 | -41.2% | 0.10% | -45.0% |
| Q3 2018 | $3,670,000 | +16.1% | 64,125 | -1.6% | 0.18% | +13.2% |
| Q2 2018 | $3,161,000 | +30.7% | 65,143 | +5.3% | 0.16% | -5.4% |
| Q1 2018 | $2,418,000 | – | 61,847 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
| NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
| Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
| SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
| Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
| RA Capital Management | 318,565 | $11,529,000 | 1.19% |
| OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
| Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
| Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
| QVT Financial LP | 636,764 | $23,044,000 | 0.87% |